Items tagged with Treatment

Frequently Asked Questions on the WHO Rapid Communication: key changes to the treatment of multidrug- and rifampicin-resistant TB (post)

The World Health Organization (WHO) in collaboration with the Stop TB Partnership’s Global Drug Facility, the Global Fund to Fight AIDS, Tuberculosis and Malaria and the United States Agency for International Development have developed a set of frequently asked questions (and answers) in response to inquiries on upcoming WHO policy recommendations.

Bangladesh, USAID DR-TB treatment project shows impacts of community-based approach (post)

A project that shifted treatment for drug-resistant tuberculosis from overburdened Bangladesh hospitals to patients’ homes saw time between diagnosis and treatment initiation drop from more than three months to less than a week, reducing risks of the continued spread of the disease, a study reported in Global Health Science and Practice found. In the process, researchers found rates of treatment success climbed from 70 percent in 2011 to 76 percent in 2015, while death rates among patients treated for drug-resistant tuberculosis dropped from 14 percent to 9 percent.

South Africa: Interim clinical guidance for the implementation of injectable-free regimens (post)

The Department of Health of South Africa released Interim clinical guidance for the implementation of injectable-free regimens for rifampicin-resistant tuberculosis in adults, adolescents and children.

Regular visual assessment required for patients on TB therapy (post)

Tuberculosis remains a major global health problem and an epidemic in countries such as India, Pakistan, Indonesia, China, Nigeria and South Africa. In 2015, there were approximately 10.4 million new cases worldwide, and TB represents one of the top 10 causes of death worldwide, according to the World Health Organization.

'Game changer' TB drug cures 9 in 10 (post)

A new treatment for a drug-resistant strain of tuberculosis can cure more than 90 percent of sufferers, according to a trial hailed Monday (October 22) as a "game changer" in the fight against the global killer.

Union launches field guide for the management of drug-resistant TB (post)

The Union launched a new technical resource on drug-resistant tuberculosis (DR-TB) management during a press conference on DR-TB at the 49^th Union World Conference on Lung Health, in The Hague, The Netherlands today (October 25).

Public health experts discuss importance of implementing guidelines, improving access to treatment for MDR-TB (post)

Pulmonary TB can be cured with shorter treatment, study finds (post)

Almost half of the nearly 10 million patients with active tuberculosis each year could potentially be cured with significantly shorter treatments than current guidelines recommend, a new analysis from UC San Francisco has found. The results suggest targeted therapies could be more effective in treating TB, which killed an estimated 1.3 million people around the world last year. 

90 percent of participants in short-course XDR-TB regimen cured after six months (post)

THE HAGUE, Netherlands – New results from the ongoing Nix-TB trial continue to confirm a short-course treatment regimen of bedaquiline – one of the two newest drugs to treat TB in half a century – linezolid and pretomanid offers a significantly improved treatment option for people infected with drug resistant forms of tuberculosis, researchers said here.

TB patients on bedaquiline have half the mortality of those not on the drug: WHO chief (post)

The WHO will be releasing new recommendations for the treatment of multidrug-resistant and rifampicin-resistant tuberculosis (MDR/RR-TB) later this year, which will speak in more detail about the usage of the new drugs bedaquiline and delamanid.